MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$432,627
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from the sale of common...
Inventory
Prepaid expenses
Others
Negative Cash Flow Breakdown
Accounts receivable
Repayment of related party note ...
Net income (loss)
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
-185,753
-229,907
-233,630
-8,782
Lease cost, net of repayments
39,366
-13,122
61,236
-
Operating expenses paid with digital assets
4
-
-
-
Accounts receivable
318,621
-320,979
336,045
-326,801
Income tax receivable
34,992
-
-
-
Inventory
-81,172
537,992
-421,152
508,981
Digital assets
-8,519
-
-
-
Deferred revenue
-74,200
-59,841
25,599
-137,668
Accrued expenses
5,761
14,824
1,271
-17,814
Accounts payable
3,441
-
-3,891
-6,471
Deposits
-
-
4,400
-
Income tax payable
-79,543
513
79,030
-
Deferred tax asset
-2,069
-
2,069
-
Prepaid expenses
-54,185
73,805
-13,523
-12,470
Net cash provided by (used in) operating activities
-541,874
-552,107
-100,696
-340,445
Purchase of intangible assets
26,958
0
10,786
0
Net cash used in investing activities
-26,958
-
-
-
Advances from related parties
0
748,120
623,984
1,030,461
Repayment of related party advances
0
150,000
990,000
850,000
Repayment of related party note payable
200,000
-
-
-
Proceeds from the sale of common stock
336,205
437,067
0
0
Net cash provided by financing activities
136,205
1,035,187
-366,016
180,461
Net increase in cash
-432,627
483,080
-477,498
-159,984
Cash at beginning of period
1,145,005
661,925
1,139,423
662,517
Cash at end of period
712,378
1,145,005
661,925
1,139,423
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the sale of
common stock
$336,205
Net cash provided by
financing activities
$136,205
(95.60%↑ Y/Y)
Canceled cashflow
$200,000
Net increase in cash
-$432,627
(-167.93%↓ Y/Y)
Canceled cashflow
$136,205
Inventory
-$81,172
(-142.68%↓ Y/Y)
Prepaid expenses
-$54,185
(-227.49%↓ Y/Y)
Lease cost, net of
repayments
$39,366
Accrued expenses
$5,761
(-68.87%↓ Y/Y)
Accounts payable
$3,441
(-59.08%↓ Y/Y)
Deferred tax asset
-$2,069
Operating expenses paid
with digital assets
$4
Repayment of related party
note payable
$200,000
Net cash provided by
(used in) operating...
-$541,874
(-188.35%↓ Y/Y)
Canceled cashflow
$185,998
Net cash used in
investing activities
-$26,958
Accounts receivable
$318,621
(9.97%↑ Y/Y)
Net income (loss)
-$185,753
(-121.00%↓ Y/Y)
Income tax payable
-$79,543
Deferred revenue
-$74,200
(-133.08%↓ Y/Y)
Income tax receivable
$34,992
Digital assets
-$8,519
Purchase of intangible
assets
$26,958
(-41.48%↓ Y/Y)
Buy us a coffee
BioScience Health Innovations, Inc. (BHIC)
BioScience Health Innovations, Inc. (BHIC)